Skip to main content
. Author manuscript; available in PMC: 2013 Jun 10.
Published in final edited form as: Virology. 2011 Apr 22;415(1):56–68. doi: 10.1016/j.virol.2011.03.025

Table 1.

Inhibitor Description & Target % Inhibition
at 1μM
Dactiniomycin Antineoplastic, intercalating agent 98
6BIO Glycogen synthase kinase 3α/β inhibitor 62
Quinine ethyl carbonate Antimalarial 34
Indirubin-3′-oxime CDK inhibitor 25
Epirubicin hydrochloride Antineoplastic 17